Journal of Clinical Medicine (Feb 2022)

Low Serum Levels of Interferon Alpha in COVID-19 Patients Are Associated with Older Age

  • Enagnon Kazali Alidjinou,
  • Mickael Hirabidian,
  • Anthony Rabat,
  • Mahdi Ouafi,
  • Magloire Pandoua Nekoua,
  • Famara Sane,
  • Julien Poissy,
  • Didier Hober,
  • The Lille COVID Research Network (LICORNE)

DOI
https://doi.org/10.3390/jcm11040961
Journal volume & issue
Vol. 11, no. 4
p. 961

Abstract

Read online

Innate immune response, especially type 1 interferon (IFN) response is considered to play a substantial role in the outcome of SARS-CoV-2 infection. A reduced and delayed IFN response has been associated with progression to severe COVID-19. In this study, we investigated levels of circulating IFNα and serum neutralizing activity in COVID-19 patients admitted to the intensive care unit. We found a significant association of levels of IFNα with age (p = 0.007). This association has also been observed in a cohort of COVID-19 outpatients with mild infection (p = 0.02). The impact of senescence on IFN response can explain the higher susceptibility of the elderly to severe COVID-19.

Keywords